Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18459815 | 0.88 | TET2 (0.54) | TET2ALDH1A1EGLN1PLA2G2A | |
| SCHEMBL17373958 | 0.85 | EGLN1 (0.56) | TET2TSHRALDH1A1EGLN1PLA2G2A | |
| SCHEMBL29004439 | 0.85 | TSHR (0.52) | TSHREPHX2LMNAALDH1A1RECQL | |
| SCHEMBL29004442 | 0.85 | TSHR (0.52) | TSHREPHX2LMNAALDH1A1RECQL | |
| SCHEMBL18724662 | 0.83 | EPHX2 (0.50) | TSHREPHX2LMNAALDH1A1RECQL | |
| SCHEMBL21467817 | 0.83 | EPHX2 (0.50) | TSHREPHX2LMNAALDH1A1RECQL | |
| SCHEMBL23269433 | 0.81 | EPHX2 (0.49) | TSHREPHX2LMNAALDH1A1PLA2G2A | |
| SCHEMBL12332686 | 0.81 | EPHX2 (0.49) | TSHREPHX2LMNAALDH1A1PLA2G2A | |
| SCHEMBL16401714 | 0.80 | EPHX2 (0.48) | TSHREPHX2LMNAALDH1A1RECQL | |
| SCHEMBL19239219 | 0.80 | TSHR (0.56) | TSHREPHX2LMNAALDH1A1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1414799-A2 | HINDERED AMINE LIGHT STABILIZERS BASED ON MULTI-FUNCTIONAL CARBONYL COMPOUNDS AND METHODS OF MAKING SAME | CYTEC TECHNOLOGY CORP. (US) | 2004-05-06 | — | — | EP | disclosed |
| US-6727300-B2 | PHOTO/THERMAL STABILITY OVER TIME | CYTEC TECHNOLOGY CORP. | 2004-04-27 | — | — | US | disclosed |
| US-6696570-B2 | ESTER/AMIDE HINDERED AMINE LIGHT STABILIZERS (HALS) COMPOUNDS, ESTER/URETHANE HALS COMPOUNDS, ESTER/OXAMATE HALS COMPOUNDS, AMIDE/OXAMIDE HALS COMPOUNDS; PHOTOSTABILITY AND HEAT RESISTANCE FOR POLYMERS | CYTEC TECHNOLOGY CORP. | 2004-02-24 | — | — | US | disclosed |
| EP-1360177-A2 | OLIGOMERIC HINDERED AMINE LIGHT STABILIZERS BASED ON MULTI-FUNCTIONAL CARBONYL COMPOUNDS AND METHODS OF MAKING SAME | Cytec Technology Corp. (US) | 2003-11-12 | — | — | EP | disclosed |
| EP-1337580-A2 | POLYMERIC ARTICLES CONTAINING HINDERED AMINE LIGHT STABILIZERS BASED ON MULTI-FUNCTIONAL CARBONYL COMPOUNDS | CYTEC TECHNOLOGY CORP. (US) | 2003-08-27 | — | — | EP | disclosed |
| EP-1330437-A1 | OLIGOMERIC HINDERED AMINE LIGHT STABILIZERS BASED ON MULTI-FUNCTIONAL CARBONYL COMPOUNDS AND METHODS OF MAKING SAME | CYTEC TECHNOLOGY CORP. (US) | 2003-07-30 | — | — | EP | disclosed |
| US-20030083498-A1 | Hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same | SASSI THOMAS P (US) | 2003-05-01 | — | — | US | disclosed |
| US-6545156-B1 | Automobile overcoatings | CYTEC TECHNOLOGY CORP. | 2003-04-08 | — | — | US | disclosed |
| US-20020161075-A1 | Polymeric articles containing hindered amine light stabilizers based on multi-functional carbonyl compounds | CYTEC TECHNOLOGY CORP. | 2002-10-31 | — | — | US | disclosed |
| WO-2002062885-A2 | POLYMERIC ARTICLES CONTAINING HINDERED AMINE LIGHT STABILIZERS BASED ON MULTI-FUNCTIONAL CARBONYL COMPOUNDS | CYTEC TECHNOLOGY CORP. (US) | 2002-08-15 | — | — | WO | disclosed |
| WO-2002059090-A2 | OLIGOMERIC HINDERED AMINE LIGHT STABILIZERS BASED ON MULTI-FUNCTIONAL CARBONYL COMPOUNDS AND METHODS OF MAKING SAME | CYTEC TECHNOLOGY CORP. (US) | 2002-08-01 | — | — | WO | disclosed |
| US-20020099218-A1 | Hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same | CYTEC TECHNOLOGY CORP. | 2002-07-25 | — | — | US | disclosed |
| WO-2002057234-A1 | OLIGOMERIC HINDERED AMINE LIGHT STABILIZERS BASED ON MULTI-FUNCTIONAL CARBONYL COMPOUNDS AND METHODS OF MAKING SAME | CYTEC TECHNOLOGY CORP. (US) | 2002-07-25 | — | — | WO | disclosed |
| WO-2002057232-A2 | HINDERED AMINE LIGHT STABILIZERS BASED ON MULTI-FUNCTIONAL CARBONYL COMPOUNDS AND METHODS OF MAKING SAME | CYTEC TECHNOLOGY CORP. (US) | 2002-07-25 | — | — | WO | disclosed |
| US-20020087000-A1 | Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same | CYTEC TECHNOLOGY CORP. | 2002-07-04 | — | — | US | disclosed |
| US-6414155-B1 | STABILIZE POLYMER COMPOSITIONS AGAINST PHOTO- AND THERMAL DEGRADATION | CYTEC TECHNOLOGY CORP. | 2002-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020087000-A1 | Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same | CBR1, CCNE2, NAF1 | TET2 1846/4885TSHR 456/4885EPHX2 157/4885 |
| US-20020099218-A1 | Hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same | CBR1, C1R, CBR3 | TET2 1153/4885TSHR 2465/4885EPHX2 1101/4885 |
| US-20030083498-A1 | Hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same | CBR1, C1R, CBR3 | TET2 1091/4885TSHR 2409/4885EPHX2 1084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.